Adults between 18 and 59 who face elevated risk of severe respiratory syncytial virus infection now have a licensed vaccine ...

Respiratory syncytial virus (RSV) has been a continuous and major cause of morbidity and mortality in babies and older people ...

Add Yahoo as a preferred source to see more of our stories on Google. The campus of Centers for Disease Control and Prevention is seen as a meeting of the Advisory Committee in Immunization Practices ...

THOUSANDS more Brits will be offered the life-saving RSV jab within months. The vaccine protects against the respiratory ...

A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting vulnerable groups that are most at risk of serious illness, including ...

Please provide your email address to receive an email when new articles are posted on . Researchers compared the outcomes of more than 40,000 infants who were immunized through nirsevimab or maternal ...

Please provide your email address to receive an email when new articles are posted on . Nirsevimab and maternal vaccination produced strong increases in RSV neutralizing antibodies in infants.

It has been a brutal viral season, but as RSV cases surged in New York, Northwell Health doctors say infant hospitalizations remained down. They credit a fairly new vaccine for that. It is ...

From September, the South West will offer the RSV vaccine from NHS to people aged 65 to 74 with a chronic respiratory condition or suppressed immune system ...

Millions more older adults will be offered a free vaccine against a potentially deadly winter virus from September, the NHS ...

As winter takes hold and more people spend time indoors, respiratory illnesses are expected to begin spreading more widely through communities. But while the seasonal return of viruses is familiar, ...